Pharma Mar Overview

  • Year Founded
  • 1986

Year Founded

  • Status
  • Public

  • Employees
  • 505

Employees

  • Stock Symbol
  • PHM

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $63.39
  • (As of Friday Closing)

Pharma Mar General Information

Description

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Avenida De los Reyes, 1
  • 28770 Colmenar Viejo
  • Spain
+34 918
Primary Industry
Other Pharmaceuticals and Biotechnology
Stock Exchange
MAD
Vertical(s)
Corporate Office
  • Avenida De los Reyes, 1
  • 28770 Colmenar Viejo
  • Spain
+34 918

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharma Mar Stock Performance

As of 20-Nov-2026, Pharma Mar’s stock price is $63.39. Its current market cap is $1.09B with 17.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$63.39 $64.95 $62.68 - $123.58 $1.09B 17.3M 35.3K $4.56

Pharma Mar Financials Summary

As of 30-Sep-2026, Pharma Mar has a trailing 12-month revenue of $320M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,293,699 1,393,110 1,332,190 657,331
Revenue 319,802 249,729 189,210 171,133
EBITDA 63,879 75,600 16,840 483
Net Income 74,671 84,585 28,270 1,230
Total Assets 463,135 464,070 363,830 376,411
Total Debt 79,457 58,044 53,147 48,272
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pharma Mar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pharma Mar‘s full profile, request access.

Request a free trial

Pharma Mar Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of mar
Other Pharmaceuticals and Biotechnology
Colmenar Viejo, Spain
505 As of 2025

Mumbai, India
 

Mumbai, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pharma Mar Competitors (5)

One of Pharma Mar’s 5 competitors is Lupin, a Corporation company based in Mumbai, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lupin Corporation Mumbai, India
Cipla Corporation Mumbai, India
Sun Pharmaceutical Industries Corporation Mumbai, India
Novartis Corporation Basel, Switzerland
Wockhardt Corporation Mumbai, India
You’re viewing 5 of 5 competitors. Get the full list »

Pharma Mar Patents

Pharma Mar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026219609-A1 Anticancer compound Pending 14-Apr-2025
WO-2026022359-A2 Synthetic process for the manufacture of ecteinascidin compounds Pending 26-Jul-2024
WO-2026022359-A3 Synthetic process for the manufacture of ecteinascidin compounds Pending 26-Jul-2024
WO-2025233522-A1 Synthetic process for an ecteinascidin Pending 10-May-2024
AU-2025265557-A1 Combination of compound ia and a topoisomerase i inhibitor in the treatment of cancer Pending 30-Apr-2024
To view Pharma Mar’s complete patent history, request access »

Pharma Mar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pharma Mar Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Pharma Mar‘s full profile, request access.

Request a free trial

Pharma Mar Acquisitions (1)

Pharma Mar’s most recent deal was a Merger/Acquisition with Zeltia. The deal was made on 02-Nov-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Zeltia 02-Nov-2014 Merger/Acquisition Biotechnology
To view Pharma Mar’s complete acquisitions history, request access »

Pharma Mar ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

24.53 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Pharma Mar’s complete esg history, request access »

Pharma Mar Exits (1)

Pharma Mar’s most recent exit was on 02-Nov-2014 from Zeltia. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Zeltia 02-Nov-2014 Completed
To view Pharma Mar’s complete exits history, request access »

Pharma Mar FAQs

  • When was Pharma Mar founded?

    Pharma Mar was founded in 1986.

  • Where is Pharma Mar headquartered?

    Pharma Mar is headquartered in Colmenar Viejo, Spain.

  • What is the size of Pharma Mar?

    Pharma Mar has 505 total employees.

  • What industry is Pharma Mar in?

    Pharma Mar’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Pharma Mar a private or public company?

    Pharma Mar is a Public company.

  • What is Pharma Mar’s stock symbol?

    The ticker symbol for Pharma Mar is PHM.

  • What is the current stock price of Pharma Mar?

    As of 20-Nov-2026 the stock price of Pharma Mar is $63.39.

  • What is the current market cap of Pharma Mar?

    The current market capitalization of Pharma Mar is $1.09B.

  • What is Pharma Mar’s current revenue?

    The trailing twelve month revenue for Pharma Mar is $320M.

  • Who are Pharma Mar’s competitors?

    Lupin, Cipla, Sun Pharmaceutical Industries, Novartis, and Wockhardt are competitors of Pharma Mar.

  • What is Pharma Mar’s annual earnings per share (EPS)?

    Pharma Mar’s EPS for 12 months was $4.56.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process